Europe:+32-2-535-7543
Asia: +65-6223-2436
Int'l: +1-860-674-8796
US: +1-866-353-3335
  • Japanese
  • Korean
  • Chinese
Cover Image

European Markets for Orthopedic Biomaterials 2011 - Bone Grafting and Hyaluronic Acid Viscosupplementation (15 Countries)

The European orthopedic biomaterials markets are expected to approach € 1 billion by 2017, with hyaluronic acid viscosupplementation as the largest segment.

The European orthopedic biomaterials markets include:

  • autologous bone grafts,
  • bone graft substitutes (BGS; segmented into allografts, demineralized bone matrices and synthetics),
  • hyaluronic acid (HA) viscosupplementation,
  • bone morphogenetic protein (BMP) growth factor therapy
  • autologous chondrocyte implantation (ACI)

The European markets include:

  • Germany,
  • France,
  • the United Kingdom,
  • Spain,
  • Italy,
  • Benelux (Belgium, the Netherlands and Luxembourg),
  • Scandinavia (Denmark, Finland, Norway and Sweden),
  • Switzerland,
  • Austria,
  • Portugal and
  • Greece

The ACI market grew most rapidly in 2010 at a rate of nearly 12%, followed by the BGS market. Within the European orthopedic biomaterials market, companies such as Fidia, Genzyme, Rottapharm/Madaus and Smith & Nephew lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2017, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

The executive summary of this report is also available for purchase.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1. TOTAL EUROPEAN ORTHOPEDIC BIOMATERIALS MARKETS
  • 1.2. AUTOGRAFTED BONE PROCEDURES
  • 1.3. BONE GRAFT SUBSTITUTE MARKET
  • 1.4. BONE MORPHOGENETIC PROTEIN GROWTH FACTOR MARKET
  • 1.5. HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
  • 1.6. AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET
  • 1.7. COMPETITIVE ANALYSIS

RESEARCH METHODOLOGY

  • 2.1. RESEARCH SCOPE
  • 2.2. IDATA' S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKETS

  • 3.1. INTRODUCTION
    • 3.1.1. Products
      • 3.1.1.1. Growth Factors
      • 3.1.1.2. Bone Graft Substitutes
      • 3.1.1.3. Hyaluronic Acid Viscosupplementation
      • 3.1.1.4. Autologous Chondrocyte Implantation
  • 3.2. CURRENCY EXCHANGE RATE
  • 3.3. MARKET OVERVIEW
  • 3.4. MARKET BY SEGMENT
  • 3.5. TREND ANALYSIS BY SEGMENT
  • 3.6. MARKET BY COUNTRY
  • 3.7. MARKET DRIVERS AND LIMITERS
    • 3.7.1. Market Drivers
    • 3.7.2. Market Limiters
  • 3.8. COMPETITIVE ANALYSIS
    • 3.8.1. Market Concentration
  • 3.9. MERGERS AND ACQUISITIONS

COUNTRY PROFILES

  • 4.1. INTRODUCTION
    • 4.1.1. Population
    • 4.1.2. GDP per Capita
    • 4.1.3. Procedures
    • 4.1.4. Price Index
  • 4.2. GERMANY
  • 4.3. FRANCE
  • 4.4. UNITED KINGDOM
  • 4.5. SPAIN
  • 4.6. ITALY
  • 4.7. BENELUX
  • 4.8. SCANDINAVIA
  • 4.9. SWITZERLAND
  • 4.10. AUSTRIA
  • 4.11. PORTUGAL
  • 4.12. GREECE

BONE GRAFT SUBSTITUTE MARKET

  • 5.1. INTRODUCTION
    • 5.1.1. Volumes Represented per Procedure
  • 5.2. MARKET OVERVIEW
    • 5.2.1. Total Bone Graft Substitute Procedures by Indication
    • 5.2.2. Total Bone Graft Substitute Procedures by Segment
    • 5.2.3. Bone Graft Substitute Average Selling Price by Segment
    • 5.2.4. Bone Graft Substitute Market by Segment
  • 5.3. MARKET ANALYSIS AND FORECAST
    • 5.3.1. Total Bone Graft Substitute Market
    • 5.3.2. Total Allograft Market
      • 5.3.2.1. Allograft Spine Market
      • 5.3.2.2. Allograft Cervical Spine Market
      • 5.3.2.3. Allograft Thoracolumbar Spine Market
      • 5.3.2.4. Allograft Trauma and Reconstruction Market
      • 5.3.2.5. Allograft Craniomaxillofacial Market
    • 5.3.3. Total Synthetic Material Market
      • 5.3.3.1. Synthetic Spine Market
      • 5.3.3.2. Synthetic Cervical Spine Market
      • 5.3.3.3. Synthetic Thoracolumbar Spine Market
      • 5.3.3.4. Synthetic Trauma and Reconstruction Market
      • 5.3.3.5. Synthetic Craniomaxillofacial Market
    • 5.3.4. Total DBM Market
      • 5.3.4.1. DBM Spine Market
      • 5.3.4.2. DBM Cervical Spine Market
      • 5.3.4.3. DBM Thoracolumbar Spine Market
      • 5.3.4.4. DBM Trauma and Reconstruction Market
      • 5.3.4.5. DBM Craniomaxillofacial Market
  • 5.4. MARKET DRIVERS AND LIMITERS
    • 5.4.1. Market Drivers
    • 5.4.2. Market Limiters
  • 5.5. COMPETITIVE ANALYSIS

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET

  • 6.1. INTRODUCTION
  • 6.2. MARKET ANALYSIS AND FORECAST
  • 6.3. MARKET DRIVERS AND LIMITERS
    • 6.3.1. Market Drivers
    • 6.3.2. Market Limiters
  • 6.4. COMPETITIVE ANALYSIS

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 7.1. INTRODUCTION
  • 7.2. MARKET OVERVIEW
  • 7.3. MARKET ANALYSIS AND FORECAST
    • 7.3.1. Total Hyaluronic Acid Viscosupplementation Market
    • 7.3.2. Single-Injection Market
    • 7.3.3. Three-Injection Cycle Market
    • 7.3.4. Five-Injection Cycle Market
  • 7.4. MARKET DRIVERS AND LIMITERS
    • 7.4.1. Market Drivers
    • 7.4.2. Market Limiters
  • 7.5. COMPETITIVE ANALYSIS

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET

  • 8.1. INTRODUCTION
  • 8.2. MARKET ANALYSIS AND FORECAST
  • 8.3. MARKET DRIVERS AND LIMITERS
    • 8.3.1. Market Drivers
    • 8.3.2. Market Limiters
  • 8.4. COMPETITIVE ANALYSIS

ABBREVIATIONS

APPENDIX: BONE CEMENT MARKET

  • 10.1. BONE CEMENT MARKET ANALYSIS AND FORECAST

LIST OF FIGURES

EXECUTIVE SUMMARY

RESEARCH METHODOLOGY

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKETS

  • Figure 3-1: Exchange Rate between Selected European Currencies and the Euro, 2010
  • Figure 3-2: Total European Orthopedic Biomaterials Market, Europe, 2007 - 2017
  • Figure 3-3: Total Orthopedic Biomaterials Market, Europe, 2007 - 2017 (€ M)
  • Figure 3-4: Total Orthopedic Biomaterials Market, Europe, 2007 - 2017 (US$M)
  • Figure 3-5: Orthopedic Biomaterials Market Growth Rates by Segment, Europe, 2007 - 2017
  • Figure 3-6: Orthopedic Biomaterials Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 3-7: Orthopedic Biomaterials Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 3-8: Market Drivers and Limiters, Orthopedic Biomaterials Market, Europe, 2010
  • Figure 3-9: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2010
  • Figure 3-10: Market Concentration, Orthopedic Biomaterials Market, Europe, 2010

COUNTRY PROFILES

  • Figure 4-1: European Price Index for BGS Materials by Country, 2010

BONE GRAFT SUBSTITUTE MARKET

  • Figure 5-1: Total Bone Graft Substitute Procedures by Indication, Europe, 2007 - 2017
  • Figure 5-2: Total Orthopedic Bone Graft Substitute Procedures by Segment, Europe, 2007 - 2017
  • Figure 5-3: Bone Graft Substitute ASP by Segment, Europe, 2007 - 2017 (€ )
  • Figure 5-4: Bone Graft Substitute ASP by Segment, Europe, 2007 - 2017 (US$)
  • Figure 5-5: Bone Graft Substitute Market by Segment, Europe, 2007 - 2017 (€ M)
  • Figure 5-6: Bone Graft Substitute Market by Segment, Europe, 2007 - 2017 (US$M)
  • Figure 5-7: Total Bone Graft Substitute Procedures by Country, Europe, 2007 - 2017
  • Figure 5-8: Total Bone Graft Substitute Units Sold by Country, Europe, 2007 - 2017
  • Figure 5-9: Total Bone Graft Substitute ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 5-10: Total Bone Graft Substitute ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 5-11: Total Bone Graft Substitute Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 5-12: Total Bone Graft Substitute Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 5-13: Total Bone Graft Substitute Market, Europe, 2007 - 2017 (€ M)
  • Figure 5-14: Total Allograft Procedures by Country, Europe, 2007 - 2017
  • Figure 5-15: Total Allograft Units Sold by Country, Europe, 2007 - 2017
  • Figure 5-16: Total Allograft ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 5-17: Total Allograft ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 5-18: Total Allograft Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 5-19: Total Allograft Market by Country, Europe, 2007-2017 (US$M)
  • Figure 5-20: Allograft Total Spine Procedures by Country, Europe, 2007 - 2017
  • Figure 5-21: Allograft Total Spine Units Sold by Country, Europe, 2007 - 2017
  • Figure 5-22: Allograft Total Spine ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 5-23: Allograft Total Spine ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 5-24: Allograft Total Spine Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 5-25: Allograft Total Spine Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 5-26: Allograft Cervical Spine Procedures by Country, Europe, 2007 - 2017
  • Figure 5-27: Allograft Cervical Spine Units Sold by Country, Europe, 2007 - 2017
  • Figure 5-28: Allograft Cervical Spine ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 5-29: Allograft Cervical Spine ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 5-30: Allograft Cervical Spine Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 5-31: Allograft Cervical Spine Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 5-32: Allograft Thoracolumbar Spine Procedures by Country, Europe, 2007 - 2017
  • Figure 5-33: Allograft Thoracolumbar Spine Units Sold by Country, Europe, 2007 - 2017
  • Figure 5-34: Allograft Thoracolumbar Spine ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 5-35: Allograft Thoracolumbar Spine ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 5-36: Allograft Thoracolumbar Spine Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 5-37: Allograft Thoracolumbar Spine Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 5-38: Allograft Trauma and Reconstruction Procedures by Country, Europe, 2007 - 2017
  • Figure 5-39: Allograft Trauma and Reconstruction Units Sold by Country, Europe, 2007 - 2017
  • Figure 5-40: Allograft Trauma and Reconstruction ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 5-41: Allograft Trauma and Reconstruction ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 5-42: Allograft Trauma and Reconstruction Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 5-43: Allograft Trauma and Reconstruction Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 5-44: Allograft Craniomaxillofacial Procedures by Country, Europe, 2007 - 2017
  • Figure 5-45: Allograft Craniomaxillofacial Units Sold by Country, Europe, 2007 - 2017
  • Figure 5-46: Allograft Craniomaxillofacial ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 5-47: Allograft Craniomaxillofacial ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 5-48: Allograft Craniomaxillofacial Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 5-49: Allograft Craniomaxillofacial Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 5-50: Total Synthetic Procedures by Country, Europe, 2007 - 2017
  • Figure 5-51: Total Synthetic Units Sold by Country, Europe, 2007 - 2017
  • Figure 5-52: Total Synthetic ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 5-53: Total Synthetic ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 5-54: Total Synthetic Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 5-55: Total Synthetic Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 5-56: Synthetic Spine Procedures by Country, Europe, 2007 - 2017
  • Figure 5-57: Synthetic Spine Units Sold by Country, Europe, 2007 - 2017
  • Figure 5-58: Synthetic Spine ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 5-59: Synthetic Spine ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 5-60: Synthetic Spine Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 5-61: Synthetic Spine Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 5-62: Synthetic Cervical Spine Procedures by Country, Europe, 2007 - 2017
  • Figure 5-63: Synthetic Cervical Spine Units Sold by Country, Europe, 2007 - 2017
  • Figure 5-64: Synthetic Cervical Spine ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 5-65: Synthetic Cervical Spine ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 5-66: Synthetic Cervical Spine Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 5-67: Synthetic Cervical Spine Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 5-68: Synthetic Thoracolumbar Spine Procedures by Country, Europe, 2007 - 2017
  • Figure 5-69: Synthetic Thoracolumbar Spine Units Sold by Country, Europe, 2007 - 2017
  • Figure 5-70: Synthetic Thoracolumbar Spine ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 5-71: Synthetic Thoracolumbar Spine ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 5-72: Synthetic Thoracolumbar Spine Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 5-73: Synthetic Thoracolumbar Spine Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 5-74: Synthetic Trauma and Reconstruction Procedures by Country, Europe, 2007 - 2017
  • Figure 5-75: Synthetic Trauma and Reconstruction Units Sold by Country, Europe, 2007 - 2017
  • Figure 5-76: Synthetic Trauma and Reconstruction ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 5-77: Synthetic Trauma and Reconstruction ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 5-78: Synthetic Trauma and Reconstruction Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 5-79: Synthetic Trauma and Reconstruction Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 5-80: Synthetic Craniomaxillofacial Procedures by Country, Europe, 2007 - 2017
  • Figure 5-81: Synthetic Craniomaxillofacial Units Sold by Country, Europe, 2007 - 2017
  • Figure 5-82: Synthetic Craniomaxillofacial ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 5-83: Synthetic Craniomaxillofacial ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 5-84: Synthetic Craniomaxillofacial Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 5-85: Synthetic Craniomaxillofacial Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 5-86: Total DBM Procedures by Country, Europe, 2007 - 2017
  • Figure 5-87: Total DBM Units Sold by Country, Europe, 2007 - 2017
  • Figure 5-88: Total DBM ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 5-89: Total DBM ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 5-90: Total DBM Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 5-91: Total DBM Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 5-92: DBM Spine Procedures by Country, Europe, 2007 - 2017
  • Figure 5-93: DBM Spine Units Sold by Country, Europe, 2007 - 2017
  • Figure 5-94: DBM Spine ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 5-95: DBM Spine ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 5-96: DBM Spine Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 5-97: DBM Spine Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 5-98: DBM Cervical Spine Procedures by Country, Europe, 2007 - 2017
  • Figure 5-99: DBM Cervical Spine Units Sold by Country, Europe, 2007 - 2017
  • Figure 5-100: DBM Cervical Spine ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 5-101: DBM Cervical Spine ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 5-102: DBM Cervical Spine Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 5-103: DBM Cervical Spine Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 5-104: DBM Thoracolumbar Spine Procedures by Country, Europe, 2007 - 2017
  • Figure 5-105: DBM Thoracolumbar Spine Units Sold by Country, Europe, 2007 - 2017
  • Figure 5-106: DBM Thoracolumbar Spine ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 5-107: DBM Thoracolumbar Spine ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 5-108: DBM Thoracolumbar Spine Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 5-109: DBM Thoracolumbar Spine Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 5-110: DBM Trauma and Reconstruction Procedures by Country, Europe, 2007 - 2017
  • Figure 5-111: DBM Trauma and Reconstruction Units Sold by Country, Europe, 2007 - 2017
  • Figure 5-112: DBM Trauma and Reconstruction ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 5-113: DBM Trauma and Reconstruction ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 5-114: DBM Trauma and Reconstruction Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 5-115: DBM Trauma and Reconstruction Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 5-116: DBM Craniomaxillofacial Procedures by Country, Europe, 2007 - 2017
  • Figure 5-117: DBM Craniomaxillofacial Units Sold by Country, Europe, 2007 - 2017
  • Figure 5-118: DBM Craniomaxillofacial ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 5-119: DBM Craniomaxillofacial ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 5-120: DBM Craniomaxillofacial Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 5-121: DBM Craniomaxillofacial Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 5-122: Drivers and Limiters, Bone Graft Substitute Market, Europe, 2007 - 2017
  • Figure 5-123: Leading Competitors, Bone Graft Substitute Market by Country, Europe, 2010

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET

  • Figure 6-1: Bone Morphogenetic Protein Growth Factor Units (Vials), Europe, 2007 - 2017
  • Figure 6-2: Bone Morphogenetic Protein Growth Factor ASP, Europe, 2007 - 2017 (€ )
  • Figure 6-3: Bone Morphogenetic Protein Growth Factor ASP, Europe, 2007 - 2017 (US$)
  • Figure 6-4: Bone Morphogenetic Protein Growth Factor Therapy Market, Europe, 2007 - 2017 (€ M)
  • Figure 6-5: Bone Morphogenetic Protein Growth Factor Therapy Market, Europe, 2007 - 2017 (US$M)
  • Figure 6-6: Drivers and Limiters, Bone Morphogenetic Growth Factor Therapy Market, Europe, 2007 - 2017
  • Figure 6-7: Leading Competitors, Bone Morphogenetic Growth Factor Therapy Market, Europe, 2010

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • Figure 7-1: Total Hyaluronic Acid Viscosupplementation Procedures by Segment, Europe, 2007 - 2017
  • Figure 7-2: Total Hyaluronic Acid Viscosupplementation ASP by Segment, Europe, 2007 - 2017 (€ )
  • Figure 7-3: Total Hyaluronic Acid Viscosupplementation ASP by Segment, Europe, 2007 - 2017 (US$)
  • Figure 7-4: Total Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2007 - 2017 (€ M)
  • Figure 7-5: Total Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2007 - 2017 (US$M)
  • Figure 7-6: Total Hyaluronic Acid Viscosupplement Injections by Country, Europe, 2007 - 2017
  • Figure 7-7: Hyaluronic Acid Viscosupplementation ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 7-8: Hyaluronic Acid Viscosupplementation ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 7-9: Total Hyaluronic Acid Viscosupplementation Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 7-10: Total Hyaluronic Acid Viscosupplementation Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 7-11: Single-Injection Procedures by Country, Europe, 2007 - 2017
  • Figure 7-12: Single-Injection ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 7-13: Single-Injection ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 7-14: Single-Injection Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 7-15: Single-Injection Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 7-16: Three-Injection Cycle Procedures by Country, Europe, 2007 - 2017
  • Figure 7-17: Three-Injection Cycle ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 7-18: Three-Injection Cycle ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 7-19: Three-Injection Cycle Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 7-20: Three-Injection Cycle Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 7-21: Five-Injection Cycle Procedures by Country, Europe, 2007 - 2017
  • Figure 7-22: Five-Injection Cycle ASP by Country, Europe, 2007 - 2017 (€ )
  • Figure 7-23: Five-Injection Cycle ASP by Country, Europe, 2007 - 2017 (US$)
  • Figure 7-24: Five-Injection Cycle Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 7-25: Five-Injection Cycle Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 7-26: Drivers and Limiters, Hyaluronic Acid Viscosupplementation Market, Europe, 2007 - 2017
  • Figure 7-27: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Europe, 2010

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET

  • Figure 8-1: Autologous Chondrocyte Implantation Market, Europe, 2007 - 2017 (€ )
  • Figure 8-2: Autologous Chondrocyte Implantation Market, Europe, 2007 - 2017 (US$)
  • Figure 8-3: Autologous Chondrocyte Implantation Units Sold by Country, Europe, 2007 - 2017
  • Figure 8-4: Autologous Chondrocyte Implantation Market by Country, Europe, 2007 - 2017 (€ M)
  • Figure 8-5: Autologous Chondrocyte Implantation Market by Country, Europe, 2007 - 2017 (US$M)
  • Figure 8-6: Drivers and Limiters, Autologous Chondrocyte Implantation Market, Europe, 2010
  • Figure 8-7: Leading Competitors, Autologous Chondrocyte Implantation Market, Europe, 2010

ABBREVIATIONS

APPENDIX: BONE CEMENT MARKET

  • Figure 10-1: Premixed Antibiotic Bone Cement Market, Europe, 2007 - 2017 (€ )
  • Figure 10-2: Premixed Antibiotic Bone Cement Market, Europe, 2007 - 2017 (US$)
  • Figure 10-3: Traditional Bone Cement Market, Europe, 2007-2017 (€ )
  • Figure 10-4: Traditional Bone Cement Market, Europe, 2007 - 2017 (US$)
  • Figure 10-5: Leading Competitors, Bone Cement Market, Europe, 2010

LIST OF CHARTS

EXECUTIVE SUMMARY

  • Chart 1-1: Total Orthopedic Biomaterials Markets, Europe, 2007 - 2017 (€ M)
  • Chart 1-2: Autograft Procedures, Europe, 2017
  • Chart 1-3: Orthopedic Procedures by Bone Graft Substitute, Europe, 2010
  • Chart 1-4: BMP Growth Factor Market, Europe, 2007 - 2017 (€ M)
  • Chart 1-5: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2007 - 2017
  • Chart 1-6: Autologous Chondrocyte Implantation Market, Europe, 2007 - 2017 (€ M)
  • Chart 1-7: Leading Competitors, Orthopedic Biomaterial Markets, Europe, 2010

RESEARCH METHODOLOGY

EUROPEAN ORTHOPEDIC BIOMATERIALS MARKETS

  • Chart 3-1: Total European Orthopedic Biomaterials Market, Europe, 2007 - 2017 (€ M)
  • Chart 3-2: Total Orthopedic Biomaterials Market by Segment, Europe, 2007 - 2017 (€ M)
  • Chart 3-3: Total Orthopedic Biomaterials Market by Segment, Europe, 2010
  • Chart 3-4: Total Orthopedic Biomaterials Market by Segment, Europe, 2017
  • Chart 3-5: Total European Orthopedic Biomaterials Market by Segment, Europe, 2008 - 2017
  • Chart 3-6: Leading Competitors, Orthopedic Biomaterials Market, Europe, 2010

COUNTRY PROFILES

  • Chart 4-1: Country Profile, Germany, 2010
  • Chart 4-2: Country Profile, France, 2010
  • Chart 4-3: Country Profile, U.K., 2010
  • Chart 4-4: Country Profile, Spain, 2010
  • Chart 4-5: Country Profile, Italy, 2010
  • Chart 4-6: Country Profile, Benelux, 2010
  • Chart 4-7: Country Profile, Scandinavia, 2010
  • Chart 4-8: Country Profile, Switzerland, 2010
  • Chart 4-9: Country Profile, Austria, 2010
  • Chart 4-10: Country Profile, Portugal, 2010
  • Chart 4-11: Country Profile, Greece, 2010

BONE GRAFT SUBSTITUTE MARKET

  • Chart 5-1: Orthopedic Bone Graft Substitute Procedures by Indication, Europe, 2010
  • Chart 5-2: Orthopedic Bone Graft Substitute Procedures by Indication, Europe, 2017
  • Chart 5-3: Total Orthopedic Bone Graft Substitute Procedures by Segment, Europe, 2010
  • Chart 5-4: Total Orthopedic Bone Graft Substitute Procedures by Segment, Europe, 2017
  • Chart 5-5: Bone Graft Substitute Market by Segment, Europe, 2007 - 2017 (€ M)
  • Chart 5-6: Bone Graft Substitute Market by Segment, Europe, 2010
  • Chart 5-7: Bone Graft Substitute Market by Segment, Europe, 2017
  • Chart 5-8: Total Allograft Market, Europe, 2007 - 2017 (€ M)
  • Chart 5-9: Allograft Total Spine Market, Europe, 2007 - 2017 (€ M)
  • Chart 5-10: Allograft Cervical Spine Market, Europe, 2007 - 2017 (€ M)
  • Chart 5-11: Allograft Thoracolumbar Spine Market, Europe, 2007 - 2017 (€ M)
  • Chart 5-12: Allograft Trauma and Reconstruction Market, Europe, 2007 - 2017 (€ M)
  • Chart 5-13: Allograft Craniomaxillofacial Market, Europe, 2007 - 2017 (€ M)
  • Chart 5-14: Total Synthetic Market, Europe, 2007 - 2017 (€ M)
  • Chart 5-15: Synthetic Spine Market, Europe, 2007 - 2017 (€ M)
  • Chart 5-16: Synthetic Cervical Spine Market, Europe, 2007 - 2017 (€ M)
  • Chart 5-17: Synthetic Thoracolumbar Spine Market, Europe, 2007 - 2017 (€ M)
  • Chart 5-18: Synthetic Trauma and Reconstruction Spine Market, Europe, 2007 - 2017 (€ M)
  • Chart 5-19: Synthetic Craniomaxillofacial Spine Market, Europe, 2007 - 2017 (€ M)
  • Chart 5-20: Total DBM Market, Europe, 2007 - 2017 (€ M)
  • Chart 5-21: DBM Spine Market, Europe, 2007 - 2017 (€ M)
  • Chart 5-22: DBM Cervical Spine Market, Europe, 2007 - 2017 (€ M)
  • Chart 5-23: DBM Thoracolumbar Spine Market, Europe, 2007 - 2017 (€ M)
  • Chart 5-24: DBM Trauma and Reconstruction Spine Market, Europe, 2007 - 2017 (€ M)
  • Chart 5-25: DBM Craniomaxillofacial Spine Market, Europe, 2007 - 2017 (€ M)
  • Chart 5-26: Leading Competitors, Bone Graft Substitute Market by Country, Europe, 2010

BONE MORPHOGENETIC PROTEIN GROWTH FACTOR THERAPY MARKET

  • Chart 6-1: Bone Morphogenetic Protein Growth Factor Therapy Market, Europe, 2007 - 2017 (€ M)
  • Chart 6-2: Leading Competitors, Bone Morphogenetic Growth Factor Therapy Market, Europe, 2010

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • Chart 7-1: Total Hyaluronic Acid Viscosupplementation Market, Europe, 2007 - 2017 (€ M)
  • Chart 7-2: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2010
  • Chart 7-3: Hyaluronic Acid Viscosupplementation Market by Segment, Europe, 2017
  • Chart 7-4: Total Single-Injection Hyaluronic Acid Viscosupplementation Market, Europe, 2007 - 2017 (€ M)
  • Chart 7-5: Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2007 - 2017 (€ M)
  • Chart 7-6: Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market, Europe, 2007 - 2017 (€ M)
  • Chart 7-7: Leading Competitors, Hyaluronic Acid Viscosupplementation Market, Europe, 2010

AUTOLOGOUS CHONDROCYTE IMPLANTATION MARKET

  • Chart 8-1: Autologous Chondrocyte Implantation Market, Europe, 2007 - 2017 (€ M)
  • Chart 8-2: Leading Competitors, Autologous Chondrocyte Implantation Market, Europe, 2010

ABBREVIATIONS

APPENDIX: BONE CEMENT MARKET

  • Chart 10-1: Leading Competitors, Bone Cement Market, Europe, 2010
Show More
Pricing